There is a logical reason why there has been no revenue.
According to Yole Intelligence the revenue forecast for the entire Neuromorphic market was 2024 was only $28mill.
See slide 6 of BRN Investor update.
The good news is that it is all up from here.
Yole forecast the market revenue forecast to be $822mill from here by 2029 - consider the BRN Roadmap in relation to this.
PowerPoint Presentation
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $394.9M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 19.0¢ | $802.7K | 4.129M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 41 | 1102480 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 710044 | 24 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| BRN (ASX) Chart |